| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.06B | +11.9% |
| Cost of Revenue | $280.2M | +21.3% |
| Gross Profit | $776.8M | +8.8% |
| R&D Expense | $227.5M | +12.9% |
| SG&A Expense | $206.6M | -5.3% |
| Operating Income | $93.8M | +17.1% |
| Interest Expense | $71.0M | +9.9% |
| Pre-tax Income | $21.5M | -51.4% |
| Income Tax | $19.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.2M | -72.1% |
| Accounts Receivable | $137.1M | +28.6% |
| Current Assets | $335.1M | -40.7% |
| Total Assets | $3.57B | +12.3% |
| Current Liabilities | $234.1M | +51.2% |
| Long-term Debt | $1.29B | +69.6% |
| Total Liabilities | $1.79B | +53.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $315.5M | +11.1% |
| Capital Expenditures | $61.0M | +15.0% |
| Investing Cash Flow | -$471.4M | -789.2% |
| Financing Cash Flow | -$132.1M | -384.0% |
| Free Cash Flow | $254.5M | +10.2% |
| +51.8% |
| Net Income | $1.7M | -94.6% |
| EPS (Basic) | $0.00 | -100.0% |
| EPS (Diluted) | $0.00 | -100.0% |
| Stockholders' Equity |
| $1.79B |
| -10.6% |